Articles By Nancy Lapid
The cumulative risks and burdens of repeat infection increased with the number of infections, even after accounting for differences in COVID-19 variants such as Delta, Omicron and BA.5, the researchers said.
Experimental Chewing Gum Reduces Omicron In Saliva; Sexual Dysfunction, Hair Loss Among Long COVID Symptoms
An experimental chewing gum that "traps" SARS-CoV-2 particles in saliva holds promise for curbing transmission of new variants of the virus, says new study. The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Among people who were previously infected with the coronavirus, a third dose of an mRNA vaccine from Pfizer/BioNTech or Moderna may not boost their protection against the Omicron variant of the virus, according to new data. The following is a summary of some recent studies on COVID-19. Among the 80,071 children with COVID-19 in the studies, 25% developed symptoms that lasted at least 4-to-12 weeks or new persistent symptoms that appeared within 12 weeks.